Study Details

Back to Search Results

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects with Painful Diabetic Peripheral Neuropathy

Terminated/Withdrawn
The study has stopped early and will not start again. Participants were not enrolled (for withdrawn studies), however if participants were enrolled, they are no longer being examined or treated.

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT02372578

Astellas Study ID

The unique identification code given by the study sponsor.

3662-CL-0049

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Neuropathic Pain

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 years - 75 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

May 2015 - May 2016

Masking

Triple (Participant, Investigator, Outcomes Assessor)

Enrollment number

115

A Phase 2a Randomized, Double-Blind, Multicenter, Placebo and Active Controlled Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects with Painful Diabetic Peripheral Neuropathy

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects with Painful Diabetic Peripheral Neuropathy? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site US10064

Metairie, United States, 70006

Site US10036

Chicago, United States, 60624

Site US10013

Kettering, United States, 45429

Site US10063

Quincy, United States, 02169

Site US10014

Duncansville, United States, 16635

Site US10043

Hazelwood, United States, 63042

Site US10047

Santa Monica, United States, 90404

Site US10051

Boston, United States, 02115

Site US10003

Oviedo, United States, 32765

Site US10005

Boynton Beach, United States, 33436

Site US10030

Medford, United States, 97504

Site US10031

San Antonio, United States, 78228

Site US10009

Aurora, United States, 60506

Site US10039

Phoenix, United States, 85023

Site US10033

Salt Lake City, United States, 84107

Site US10049

The Villages, United States, 32162

Site US10018

Clearwater, United States, 33765

Site US10046

Orlando, United States, 32806

Site US10001

Anniston, United States, 36207

Site US10025

Evansville, United States, 47714

Site US10026

New Bedford, United States, 02740-2133

Site US10020

Lomita, United States, 90717

Site US10019

Deland, United States, 32720

Site US10008

Ormond Beach, United States, 32174

Site US10054

Fresno, United States, 93720

Site US10041

MiamiLakes, United States, 33014

Site US10027

Pasadena, United States, 21122

Site US10004

Homestead, United States, 33030

Site US10053

Fairfield, United States, 06824

Site US10023

Bradenton, United States, 34205

Site US10032

San Antonio, United States, 78218

Site US10042

Jacksonville, United States, 32256

Site US10045

Renton, United States, 98057

Site US10034

Austin, United States, 78731

Site US10017

Tustin, United States, 92780

Site US10007

Jupiter, United States, 33458

Site US10055

Walnut Creek, United States, 94598

Site US10015

Greer, United States, 29651

Site US10040

Houston, United States, 77030

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo